GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Plans » Magellan Health Inc (NAS:MGLN) » Definitions » 14-Day RSI

Magellan Health (Magellan Health) 14-Day RSI : N/A (As of May. 05, 2024)


View and export this data going back to 2004. Start your Free Trial

What is Magellan Health 14-Day RSI?

The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.

As of today (2024-05-05), Magellan Health's 14-Day RSI is N/A.

The industry rank for Magellan Health's 14-Day RSI or its related term are showing as below:

MGLN's 14-Day RSI is not ranked *
in the Healthcare Plans industry.
Industry Median: 50.39
* Ranked among companies with meaningful 14-Day RSI only.

Competitive Comparison of Magellan Health's 14-Day RSI

For the Healthcare Plans subindustry, Magellan Health's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Magellan Health's 14-Day RSI Distribution in the Healthcare Plans Industry

For the Healthcare Plans industry and Healthcare sector, Magellan Health's 14-Day RSI distribution charts can be found below:

* The bar in red indicates where Magellan Health's 14-Day RSI falls into.



Magellan Health  (NAS:MGLN) 14-Day RSI Calculation

The formula for calculating RSI is:

RSI=100[ 100 / ( 1 + Average Gain / Average Loss )]

* Note that the formula uses a positive value for the average loss.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Magellan Health  (NAS:MGLN) 14-Day RSI Explanation

The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.

Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.

RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.


Magellan Health 14-Day RSI Related Terms

Thank you for viewing the detailed overview of Magellan Health's 14-Day RSI provided by GuruFocus.com. Please click on the following links to see related term pages.


Magellan Health (Magellan Health) Business Description

Traded in Other Exchanges
N/A
Address
4801 E. Washington Street, Suite 4400, Phoenix, AZ, USA, 85034
Magellan Health provides healthcare management services to health plans and other managed care organizations, employers, labor unions, United States government agencies, and third-party administrators. The firm operates in three segments: Healthcare, Pharmacy Management, and Corporate. The Healthcare business manages behavioral healthcare services and employee assistance program services, as well as specialty areas like diagnostic imaging. The Pharmacy Management segment includes pharmacy benefit management (PBM) services, pharmacy benefit administration for Medicaid and other government-sponsored programs, pharmaceutical dispensing operations, and clinical and formulary management programs. The Healthcare business generates the majority of revenue.
Executives
Mostafa Kamal officer: CEO, Magellan Rx Management 15950 NORTH 76TH STREET, #200 SCOTTSDALE AZ 85260
Jeffrey N West officer: SVP & Controller 6950 COLUMBIA GATEWAY DR STE 400 COLUMBIA MD 21046
David Bourdon officer: Chief Financial Officer 6303 COWBOYS WAY, SUITE 350, FRISCO TX 75034
Peter A Feld director 201 E LAS OLAS BOULEVARD, SUITE 1000, FORT LAUDERDALE FL 33301
Swati Bargotra Abbott director 4800 NORTH SCOTTSDALE ROAD, SUITE 4400, SCOTTSDALE AZ 85251
Steven J Shulman director 1564 NE EXPRESSWAY, ATTN: BJ PURCELL, ATLANTA GA 30329
Guy P Sansone director C/O MEDNAX, 1301 CONCORD TERRACE, SUNRISE FL 33323
Gregory Scott Mackenzie director NDC PLAZA ATLANTA GA 30329
Leslie V Norwalk director C/O 3661 VALLEY CENTRE DRIVE SUITE 200, SAN DIEGO CA 92130
Christopher J Chen director 4801 EAST WASHINGTON STREET PHOENIX AZ 85034
Mural R Josephson director
James E Murray officer: President and COO 500 WEST MAIN STREET, LOUISVILLE KY 40202
Clapper Caskie Lewis officer: Chief Human Resources Officer 55 NOD ROAD AVON CT 06001
Kenneth J Fasola director, officer: Chief Executive Officer 500 WEST MAIN STREET, LOUISVILLE KY 40202
Jonathan N Rubin officer: Chief Financial Officer 55 NOD ROAD AVON CT 06001

Magellan Health (Magellan Health) Headlines

From GuruFocus